Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification.

Zhang, Yubao; Ma, Xiaoran; Li, Huayao; Zhuang, Jing; Feng, Fubin; Liu, Lijuan; Liu, Cun; Sun, Changgang

Zhang, Yubao; Ma, Xiaoran; Li, Huayao; Zhuang, Jing; Feng, Fubin; Liu, Lijuan; Liu, Cun; Sun, Changgang.

Afiliação

Zhang Y; School of Basic Medicine, Qingdao University, Qingdao, China.
Ma X; First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Li H; College of Basic Medical, Shandong University of Traditional Chinese Medicine, Jinan, China.
Zhuang J; Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, China.
Feng F; Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, China.
Liu L; Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, China.
Liu C; First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Sun C; Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, China.

Front Pharmacol ; 12: 685773, 2021.

Article em En | MEDLINE | ID: mdl-34858165

Palavras-chave

antiproliferative; molecular docking; network pharmacology; triple-negative breast cancer; ursolic acid

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google